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Abstract
Motivation: Metabolomics involves the characterisation, identification, and quantification of small
molecules (metabolites) that act as the reaction intermediates of biological processes. Over the past
few years, we have seen wide scale improvements in data processing, database, and statistical analysis
tools. Direct infusion mass spectrometery (DIMS) is a widely used platform that is able to produce a
global fingerprint of the metabolome, without the requirement of a prior chromatographic step - making it
ideal for wide scale high-throughput metabolomics analysis. In spite of these developments, metabolite
identification still remains a key bottleneck in untargeted mass spectrometry-based metabolomics studies.
The first step of the metabolite identification task is to query masses against a metaboite database to get
putative metabolite annotations. Each existing metabolite database differs in a number of aspects including
coverage, format, and accessibility - often limiting the user to a rudimentary web interface. Manually
combining multiple search results for a single experiment where there may be potentially hundreds of
masses to investigate becomes an incredibly arduous task.
Results: To facilitate unified access to metabolite information we have created the Direct Infusion
MEtabolite database (DIMEdb), a comprehensive web-based metabolite database that contains over
80,000 metabolites sourced from a number of renowned metabolite databases of which can be utilised
in the analysis and annotation of DIMS data. To demostrate the efficacy of DIMEdb, a simple use case
for metabolic identification is presented. DIMEdb aims to provide a single point of access to metabolite
information, and hopefully facilitate the development of much needed bioinformatic tools.
Availability: DIMEdb is freely available at https://dimedb.ibers.aber.ac.uk.
Contact: keo7@aber.ac.uk
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
Metabolomics is the global study of naturally occuring low molecular
weight organic molecules (metabolites) within cell, tissue, organ, or
biofluid (German et al., 2005) - providing a ‘snapshot’ of an organism’s
metabolic state. The analysis of numerous metabolites is a growing area
of analytical biochemistry. Metabolites act as the reaction intermediates of
multiple biological processes, and are considered to be the key indicator
of biochemical activities within an organism (Schmidt, 2004). Therefore
metabolomics is widely used to a number of fields including plant science,
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toxicology, food science and biomedical research (O’Shea et al., 2016;
Stewart and Bolt, 2011; Mamas et al., 2011).
Mass-spectrometry (MS)-based metabolomics studies are often
separated into three main categories: targeted (Weljie et al., 2006), semi-
targeted (Burgess et al., 2011), and untargeted analysis (De Vos et al.,
2007). Each strategy differs in multiple aspects including the quantification
method (relative or absolute), sample preparation protocols, spectral
accuracy, spectral resolution, the total number of metabolites detected,
and even the overall study objective. In targeted and semi-targeted analysis
the metabolite composition of the studied material is known prior to any
experimentation. Whilst this approach greatly simplifies the metabolite
identification process, there is a limit to the number of commercially
available standards, greatly inhibiting the potentiality of scientifically
interesting novel discoveries. Untargeted analysis, commonly referred
to as metabolite ‘fingerprinting’, describes the study of the global
metabolome of the studied species. Whilst this approach often results in
the most diverse and comprehensive snapshot of the studied metabolome,
it greatly inhibits accurate metabolite identification.
There exists an array of analytical platforms, suited for metabolomic
analysis, however the two technologies synonymous with the field are
mass spectroscopy (MS) (Dettmer et al., 2007) and nuclear magnetic
resonance (NMR) (Lin et al., 2007) - both of which are capable of
producing high dimensional high resolution quantitative metabolite data.
MS utilises the formation of positive and/or negatively charged ions from
a given metabolite in the sample before ion separation in accordance to
mass-to-charge ratios (m/z). MS platforms including gas-chromatography
mass spectroscopy (GC-MS) (Kanani et al., 2008)), liquid chromatography
(LC-MS) (De Vos et al., 2007) and their ultra-high performance (UHP)
successors (Roux et al., 2012) are the most prevalent platforms for the
global analysis of the metabolome. Despite their popularity, both platforms
suffer from their own restrictions. For example, in GC-MS only volatile
metabolites are quantified. LC-MS is known to show inconsistencies
in peak quality and retention time - resulting in poor peak alignment
and misalignment and leading to a potentially misreported analysis.
Moreover, the requirement of prior chromatographic separation before
analysis makes performing large-scale high-throughput MS assays using
these technologies a time-consuming and physically exhaustive process.
Recently the use of direct infusion mass spectroscopy (DIMS) has become
a popular platform for high-throughput metabolomic analyses (Koulman
et al., 2007). DIMS skips the chromatographic step in its entirety, instead
allow for samples to be directly introduced to the mass spectrometer - a task
which can be automated through the use of flow injection technologies.
The identification of even a few metabolites within spectrum produced
from untargeted mass spectrometry analysis is both incredibly challenging
and labour intensive (Moco et al., 2007), and despite vast advancement
in analysis technology and protocols still remains a major bottleneck
to users (Dunn et al., 2013). When attempting to identify metabolites
found within metabolomic samples, consideration needs to be made for
only the differences between metabolites of different nominal mass - but
more often than not between metabolites with the same nominal mass
yet dissimilar molecular composition. Moreover, MS-based metabolomics
detects metabolites as a collection of derived species, and thus correctly
identifying the peak (or parent) metabolite is essential for accurate
identification. Another major issue facing the identification task is that the
complete composition of the metabolome remains unknown (Nakabayashi
and Saito, 2013) - making the unambiguous identification of metaboloties
within untargeted mass spectrum without the use of further chemical
analysis unachievable in many cases. In accordance to guidelines set out
by the Metabolomics Standards Initiative (MSI), the identification of a
metabolite at the highest confidence level (1) requires comparisons of a
species orthogonal properties against an authentic standard measured with
the exact same experimental conditions. Unfortunately due to the lack of
available authentic compounds, this form of metabolite identification may
be impossible to achieve in many cases (Sumner et al., 2007).
There exists a number of online metabolomics databases that can be
utilised for the identification of metabolites from a given mass spectra.
These databases often differ in their coverage, with many being species
or organism-specific (e.g. Human Metabolite Database (HMDB) (Wishart
et al., 2007), Seaweed Metabolite Database (SWMD) (Davis and Vasanthi,
2011), Metabolome Tomato Database (MoToDB) (Moco et al., 2006)), or
only suited for a specific analytic tool (i.e, for GC-MS; GOLM Hummel
et al. (2007)). Moreover, existing databases that have attempted to collate
an extensive integrative DIMS-compliant platform are no longer regulary
maintained or updated (e.g. MZedDB Draper et al. (2009)). As it is
desirable to perform mass search over multiple datasets (as to both confirm
results), researchers are having to manually perform this task ask each
metabolite spectral resource limits its data through only a web application.
Hence, there is a need for both user-friendly and programmatic access to
a well curated up-to-date metabolite database.
To this end, we have developed the Direct Infusion MEtabolomics
database (DIMEdb), which provides both programmatic and user
friendly interfaces to an integrated metabolite database - sourced from
multiple popular metabolomic and chemical databases. In addition to
providing a web-based front end to metabolite data, we hope to enable
bioinformaticians to build and extend much needed bioinformatic tools
for the analysis and integration of metabolite-related data.
2 Methods
2.1 Database construction
We chose a number of highly populated metabolite databases including
HMDB, PubChem, CHEBI, BioCyc, and KEGG for integration. As each
of these databases came in unique formats they were combined into a
standard form containing key attributes including naming conventions,
unique identifiers (namely Simplified Molecular Input Line Entry System
representation (SMILES) and/or IUPAC International Chemical Identifier
(InChI) where available), and physciochemical information. Upon
inspection, we found that physciochemical information found throughout
these databases was prone to a high level of variability. Moreover, chemical
databases (such as PubChem and BioCyc) presented information as a
charged molecule. As a result of this, an in-silico approach (using the
RDKit (Landrum, 2006) cheminformatics toolkit) was used to calculate
the physicochemical for each given metabolite. Once physicochemical
properties were calculated, molecule entries were combined through the
use of a generated InChIKey - a 25 character hashed representation of the
InChI identifier. In instances where unexpected collisions were present
(e.g. the presence of corrupted hashed keys), the BridgeDb identification
mapping service (van Iersel et al., 2010) was used to match entries in
accordance to external resources (including KEGG, HMDB, BioCyc,
MetaCyc). As to filter out redundant compounds, entries with less than
6 elements were removed.
As metabolites exist within a biological context, integration of
metabolite networks and biological pathway information was vital in
enhancing the metabolite identification process. Whilst some collated
databases contained pathway/network information, most databases did
not. Using mapped metabolites and their given accessions, we were able
to make use of web services provided by BioCyc (Caspi et al., 2007),
KEGG (Kanehisa and Goto, 2000), and SMPDB (Frolkis et al., 2009) to
retrieve pathway information and integreate contextual information into
our database.
As noted earlier, in-source fragmentation of molecules are able
to provide key structural information that can be used for metabolite
identification. Using adjusted molecular formulae, it is possible to
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calculate accurate masses given likely ionisation rules (Keller et al., 2008).
Unfortunately existing in-silico molecular weight calculators are closed off
for programmatic use, making them impractical for database composition.
The Python Isotopic Distribution Calculator (O’Shea, 2017) was written
and released to calculate mass spectrometry adducts.
2.2 Interface
To facilitate greater extensibility, every possible effort has been made to
ensure that DIMEdb’s underlying architecture is as modular as possible.
DIMEdb can be broken down into two main facets; a Representational
State Transfer Application Programming Interface (RESTful API), and
a web application that makes use of the API to query and interface the
generated metabolites a user-friendly web interface (Figure 1).
The web interface provides two different methods of searching the
metabolite database; a text-based search and a precursor mass search. The
text-base search page facilitates users to search the metabolite database by
searching by a number of parameters - including the systematic chemical
name, chemical nomenclature provided through literature and existing
databases, database accessions (including HMDB, ChEBI, PubChem,
KEGG, CAS, and Wikidata), InChI, InChI Key, SMILES and molecular
formula. The results pane displays a table containing all metabolites
matching the user specified search criteria. The results table contains a
2D graphical representation of the metabolite, metabolite name, molecular
formula, and monoisotopic weight.
A
B
Fig. 1. Screenshots of the DIMEdb web interface. Panel A shows results for a list of
mass queries. Panel B provides detailed metabolite information, including identification
information, adduct information, a 2D visual representation, external resources, and
contextual information for sucrose.
In addition to text search, mass-based search facilities are provided
which allows for metabolite identification from a batch of precursor mass-
to-ions. The user may also choose to set parameters such as adducts and
a mass tolerance, as to better limit the search space. Using this tool,
users are able to determine the molecular formula and potential chemical
annotations for a given batch of mass values.
RESTful APIs provide an interface via which programs and web
services can query and retrieve information that corresponds to the user’s
request. Queries can be sent through an HTTP POST request to the
URL that specifies a given resource, which will instruct the server to
produce information of interest. DIMEdb’s web service is detailed on
the online documentation, empowering users to create web service clients
that can make use of our comprehensive metabolite database for their
own applications. To demonstrate this functionality, an example Python
client has been written and can be found in the aforementioned DIMEdb
documentation.
2.3 Implementation
DIMEdb is built on the Python Flask (http://flask.pocoo.org/)
web application microframework. Metabolite information is stored in
the document-orientated MongoDB database. User account information
is stored in a relational Postgresql database, and encrypted using the
bcrypt Python package. Using a high performance document-orientated
database enables us to provide a substantial database on a low-cost
virtual machine without taking a substantial performance decrease when
indexing the database. The DIMEdb RESTful API was implemented
using the Python Eve (http://python-eve.org/) framework, with
custom interfaces written using PyMongo (https://api.mongodb.
com/python/current/). The web interface was written in the Jinja
templating engine, using Bootstrap and numerous JavaScript libraries to
enable a rich user interface.
3 Results and Discussion
To demonstrate the effectiveness of the DIMEdb platform, solutions of
sugars (sucrose, maltose, galactose), amino acids (alanine, threonine,
aspartic acid) and fatty acids (palmitic acid, stearic acid, pentadecanoic
acid) were prepared in 75% methanol/water (v/v) for identification
purposes. Cocktails of four mixes were made with all the compounds
but at different concentrations in each mix. In the sample mix A, sucrose
(10mM) is the highest whereas pentadecanoic acid (0.08mM) is the lowest
concentrated compounds. Mix B contains more concentration of threonine
(10mM) and less of palmitic acid (0.08mM). The Mix C is made up
of increased concentration of sucrose (5mM) and decreased stearic acid
(0.03mM). In mix D, threonine (0.5mM) is in excess and pentadecanoic
acid (0.003mM) is low compared to all other compounds. A master mix
is made by blending all the 4 sample mixes, and 75% methanol is used as
a blank. The randomised sample injections were preceded for metabolite
profiling by flow infusion into a Thermo ScientificTM ExactiveTM Plus
Orbitrap Mass Spectrometer. The Theano RAW data files were converted
into the open standard mzML file format (Martens et al., 2011), before
being processed.
3.1 Metabolomics data processing
Metabolomic processing steps detailed have been reported as suggested
by the Metabolomics Standards Initiative (?) using the dimspy package
(O’Shea, 2018). Whereas other forms of MS produces multiple ‘scans’
to be aligned into a single spectrum (feature matrix) through the use of
spectral alignment tools, DIMS produces a single summed (or averaged)
matrix consisting only of masses and intensities - disposing of the
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retention time property altogether (Castrillo et al., 2003). Generated
mzML files were analysed by their total ion count (TIC) to check for
any unusual samples (where ionisation had failed, or an instrumental error
had occurred) - from which no samples were found to be erroneous. As to
improve the signal quality and reduce artifacts, several pre-processing steps
were applied. Adaptive iteratively reweighted Penalized Least Squares
(airPLS) baseline correction (Zhang and Liang, 2012) was employed to
remove low frequency ‘noisy’ artifacts that were produced by experimental
and instrumental conditions.
Baseline corrected data was then subjected to peak detection and
alignment, in which peaks were identified using a Gaussian wave
filter, where a Gaussian filter is applied to the spectrum before being
centroided to locate peaks within the spectrum (Smith et al., 2006).
Standard metabolomic-analysis protocols make use of statistical methods
to determine masses of interest. As we had no phenotype criteria of which
to highlight affecting metabolites, we resorted to simply comparing the
mix spectra to clean (empty) runs to locate the presence of any substantial
peak differences. The peaks with the largest log-fold change between the
samples were taken forward for metabolite identification.
3.2 Metabolite identification with isotopic distribution
matching
Even with advent of ultra-high resolution mass spectrometers, it is not
always possible to accurately identify metabolites using just the mass
value. As to to reduce the enormity of the mass-search space, it is important
to consider a number of molecular properties. Data produced from DIMS
produces thousands of metabolite features, where a single metabolite
may be detected as multiple separate features (including protonated
and deprotonated ions, adducts, and isotopomers). Isotope identification
allows us to significantly scale down the search-space through limiting the
potential adduct relationship found for a given mass.
There exists a number of computational methodologies for the
identification of metabolites using adduct and isotopic pattern information
(Uppal et al., 2017; Brown et al., 2009; Silva et al., 2014). However, we
have opted to use a commonly used pairwise correlation analysis-based
approach for ion and isotope identification. Pearson’s pairwise correlation
analysis of all the masses in the processed feature matrix was calculated
using the Pandas data analysis package (McKinney, 2011). This produced
a matrix of correlation coefficients for pairs of masses, which indicates the
likelihood of mass pairs coming from the products of the same metablilte.
Only feature pairs of which showed a coefficient score of≥ 0.9 correlation
values were kept for further analysis.
Agglomorative clustering were performed using the complete linkage
algorithm to locate clusters of correlating masses, from which a
dendrogram was produced to help visualise the identified relationship
clusters - highlight potential presence of an isotope pattern. Using one
of the key mass signals that was shown to be a clear differentiator between
clean and mix sample (203 m/z), two additional signals were found to have
been highly correlated (204 and 205 m/z). On further manual inspection,
the isotopic pattern was shown to match that of a Na- adduct - with 203
m/z being the peak abundance.
Using this information a simple paramaterised mass search was
conducted using the DIMEdb web interface, limiting the search to +/-
0.25 m/z of 203.053 m/z (the averaged accurate mass found within the
peak bin) of all positivie charged metabolite entries featuring a [M+Na]1+
ion type. This returned a total of 4 metabolite entries, of which all had
the same nominal chemical formula (C6H12O6) - corresponding to a
monosaccharide galactose. This process was repeated in both positive and
negative mode ionisation mode spectrum (results can be found in Table 1).
Compound Stock Polarity Mass-to-ion Ion Type
Sucrose 100mM + 343.1 [M+H]1+
- 377.087 [M+Cl]1-
Maltose 100mM + 343.1 [M+H]1+
- 377.087 [M+Cl]1-
Galactose 100mM + 203.139 [M+Na]1+
- 215.031 [M+Cl]1-
Alanine 100mM + 90.053 [M+H]1+
- 88.009 [M-H]1-
Theronine 100mM + 120.06 [M+H]1+
- 119.053 [M1-.]1-
Aspartic Acid 100mM + 134.045 [M+H]1+
- 133.029 [M1-.]1-
Palmitic Acid 1mM + N/A N/A
- 255.072 [M1-.]1-
Stearic Acid 1mM + 361.153 [M+2K-H]1-
- 281.1 [M1-.]1-
Pentadecanoic acid 1mM + N/A N/A
- 242.22 [M1-.]1-
Table 1. Metabolite annotation table of mass values identified from both positive
and negatively charged FIE-MS. As expected smaller quantities of fatty acids
did not show up in positive polarity mass spectrum.
4 Conclusions and Future Work
There is an abundance of chemical and metabolite information readily
available in the public domain. Unfortunately, making use of this vast
array of information is difficult due to a lack of standard formatting and
data interrogation techniques. We have developed DIMEdb with the goal
of centeralising multiple renowned metabolite databases into an easily
accessible and highly functional web service. We have curated thousands
of metabolites, and through our powerful data generator have been able to
assure a high level of data quality. We are continuously releasing revised
versions of the database with both new and curated data, and hope to
facilitate user driven revisions in the near future. Moreover, it is our
goal to further enhance contextual analysis of metabolites through the
incorporation of pathway and metabolite network analysis tools.
DIMEdb is freely available to download and use under the open source
MIT license, and can be freely accessed at https://dimedb.ibers.
aber.ac.uk. Full documentation and additional software packages can
be located at http://dimedb.ibers.aber.ac.uk/help.
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